Skip to contentE
Electromedical Technologies, Inc
E
EMEDElectromedical Technologies, Inc Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$351.60K$351.60Kderived−16.9% vs Q4 2022 Net Income-$348.66K-$348.66KderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Electromedical Technologies, Inc · CIK 1715819 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$270,944−18.6% Operating Incomederived-$222,971N/M Operating Cash Flowderived-$50,948N/M Free Cash Flowderived-$50,948— Margins · derivedGross margin77.1%−1.6 pt vs Q4 2022
Operating margin-63.4%−2.6 pt vs Q4 2022
Net margin-99.2%+97.0 pt vs Q4 2022
ended Dec 31, 2023 · filed May 1, 2024 · 122 d after period end